Bank of America Corporation »

Kymera Therapeutics shares owned by Bank of America Corporation

Quarter-by-quarter ownership of Kymera Therapeutics (KYMR) shares owned by Bank of America Corporation from 13F filings

Historical chart of Bank of America Corporation investment in Kymera Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Kymera Therapeutics held by Bank of America Corporation consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kymera Therapeutics by Bank of America Corporation

Quarter filed Position value Share count Share price at filing
2023-12-31 $764k 30k 25.46
2023-09-30 $1.2M 89k 13.90
2023-06-30 $3.2M 140k 22.99
2023-03-31 $8.2M 277k 29.63
2022-12-31 $5.2M 207k 24.96
2022-06-30 $2.3M 119k 19.70
2021-12-31 $4.6M 72k 63.49
2021-06-30 $405k 8.4k 48.51
2021-03-31 $1.3M 32k 38.84
2020-12-31 $236k 3.8k 62.00
2020-09-30 $79k 2.4k 32.28